Summary of Purpose
SEDMAN study is a prospective multicenter investigator initiated study (IIS). The main idea is to look by Genome Wide Association (arrays that determine more than 1 million polymorphisms) genetic risk factors associated with response to dabigatran. To conduct the study, the goal is to recruit 300 patients with ischemic stroke with cardioembolic etiology treated with dabigatran and 200 treated with Acenocoumarol...Read More →
The following dates are available for this trial. Trial information last updated on 28 June 2016.
|1 Jun 2016||8 Apr 2016||1 Apr 2017||Unavailable||1 Jun 2016||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Observation: Case Control
- Perspective: Prospective
- Sampling: Non-Probability Sample